GPR35 and Parkinson disease: Through FMT and multi-omics analysis, we reveal that Gpr35 modulates PD pathogenesis by regulating the gut microbiota, particularly lactic acid bacteria, and metabolites related to neurotransmitters and lipid metabolism.